#
info@crystallizationsummit.com
English
English
Bangla
French
Spanish
Arabic
Office Address
info@crystallizationsummit.com
Phone: +1 732-978-0828
Pinterest
Social List
Home
About
Purpose
Typical Attendees
Organizer
Programs
2024
Organizing Committee
Venue
2023
Program Schedule
Sponsors
2022
2022 Report
Program
2021
2021 Report
2020
2020 Report
Spotlights
Publication Highlights
Speaker Publication 2022
Speaker Activities
Relevant Events
Registration
2023 Registration
Courtesy Cancelation
Blog Grid
Home
Blog Grid
pcs2023-abstracts ,
pcs2023 ,
session-1-enable-greener-ds-synthetic-route
Development of a scalable atroposelective process to MRTX1719-an inhibitor of the PRMT5*MTA complex
August 16, 2023
wpadm
pcs2023-abstracts ,
pcs2023 ,
session-2-enable-desired-ds-quality-attributes
Drug Substance Physical Property Control in the Process of Crystallization
August 16, 2023
wpadm
pcs2023-abstracts ,
pcs2023 ,
session-1-enable-greener-ds-synthetic-route
Enabling efficient synthetic route selection by robust purification in crystallization
August 16, 2023
wpadm
pcs2023-speakers ,
pcs2023 ,
session-1-enable-greener-ds-synthetic-route
Dr. Fredrik Nordstrom
August 16, 2023
wpadm
pcs2022-speakers ,
panel-discussions ,
pcs2022
Dr. Luca Iuzzolino, Merck & Co.
September 29, 2022
wpadm
pcs2022-speakers ,
pcs2022pd-03 ,
pcs2022
Dr. Vivian Bi, Aclaris Therapeutics
September 26, 2022
wpadm
1
2
3
4
5
6
7
8
9
…
15
16
17
